Ayr Wellness (OTCMKTS:AYRWF – Get Free Report) and Abbott Laboratories (NYSE:ABT – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk.
Volatility and Risk
Ayr Wellness has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500.
Profitability
This table compares Ayr Wellness and Abbott Laboratories’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ayr Wellness | N/A | N/A | N/A |
| Abbott Laboratories | 13.90% | 17.62% | 10.01% |
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ayr Wellness | $463.63 million | 0.00 | -$359.31 million | ($2.67) | -0.01 |
| Abbott Laboratories | $44.33 billion | 3.47 | $6.52 billion | $3.57 | 24.76 |
Abbott Laboratories has higher revenue and earnings than Ayr Wellness. Ayr Wellness is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent recommendations for Ayr Wellness and Abbott Laboratories, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ayr Wellness | 0 | 0 | 0 | 0 | 0.00 |
| Abbott Laboratories | 0 | 5 | 19 | 2 | 2.88 |
Abbott Laboratories has a consensus price target of $119.43, indicating a potential upside of 35.14%. Given Abbott Laboratories’ stronger consensus rating and higher probable upside, analysts plainly believe Abbott Laboratories is more favorable than Ayr Wellness.
Insider and Institutional Ownership
0.9% of Ayr Wellness shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 8.1% of Ayr Wellness shares are held by insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Summary
Abbott Laboratories beats Ayr Wellness on 13 of the 15 factors compared between the two stocks.
About Ayr Wellness
Ayr Wellness Inc. operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière’s disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Receive News & Ratings for Ayr Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayr Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.gif){kind=logo}
